-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
- Healthcare Area
- Resource Type
- Programme
- Year
-
NICE STA Guidance no 283 - Macular oedema (retinal vein occlusion) - ranibizumab
- Published
- 22 May 2013
- Cycle of Improvement
- Evidence
-
Second-eye cataract surgery: Advice Statement 008-12
- Published
- 11 September 2012
- Cycle of Improvement
- Evidence
-
First-eye cataract surgery: Technologies scoping report 9
- Published
- 11 September 2012
- Cycle of Improvement
- Evidence
-
First-eye cataract surgery: Advice Statement 007-12
- Published
- 11 September 2012
- Cycle of Improvement
- Evidence
-
Second-eye cataract surgery: Technologies scoping report 8
- Published
- 10 September 2012
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 155 – Ranibizumab and Pegaptanib for Age-related Macular Degeneration
- Published
- 23 May 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance No 237 – Ranibizumab for the treatment of diabetic macular oedema
- Published
- 30 November 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 229 – Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal
- Published
- 27 July 2011
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2008-003
- Published
- 05 November 2008
- Cycle of Improvement
- Evidence
-
1: Organisation of services for diabetic retinopathy screening
- Published
- 01 April 2004
- Cycle of Improvement
- Evidence
- 1
- 2